🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

Health X Platform Limited HEALTHX NSEPHARMA

Healthcare · Pharmaceutical Retailers · India
https://www.sastasundarventures.com
Company Profile ↓
₹341.55
+27.49% 1Y
Mkt Cap₹1,086.49 Cr
P/E-11.92
P/B1.68
52W High₹341.55
52W Low₹256.95
Book Value₹201.47
EPS (TTM)₹-28.66

Company Overview

Health X Platform Limited operates a digital network of healthcare and portfolio management services in India. The company operates through the Financial Services and Healthcare Network segments. It is involved in the financing of loans; investment in shares and securities; and activities for pathology and marketing of healthcare and OTC products through e-commerce portal. The company also provides financial consultancy, professional fees, wealth management, financial planning, distribution, and related services, as well as diagnostic services, including pathological/radiological investigation. In addition, it operates digital platforms for healthcare, including the Sastasundar app, a consumer-focused digital healthcare platform consisting of pharmacy, diagnostics, and wellness; and retailershakti.com, a B2B digital platform for pharmaceutical and wellness products. The company was formerly known as Sastasundar Ventures Limited Limited and changed its name to Health X Platform Limited in February 2026. Health X Platform Limited was incorporated in 1989 and is based in Kolkata, India.

Why Investors Should Care

Consistent Profit Growth

Net profit has compounded at 33.9% per year over the last five years.

Recent Developments

  • Mar 2026 Revenue of ₹1,307.65 Cr (+20.0% YoY); net profit ₹1.18 Cr.
  • Trailing 12 Months Year-on-year growth — revenue +20.0%.
  • 5-Year Trend Long-term compounding — revenue CAGR 8.0%, profit CAGR 33.9%.

Growth & Price Performance

Compounded Sales Growth

5 Years:8.00%
1 Year:20.02%

Compounded Profit Growth

5 Years:33.88%
1 Year:-

Stock Price Performance

1 Year:+27.49%
6 Months:+6.55%
3 Months:+25.39%
1 Month:+13.94%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bullish
52-Week Range 100% of range
₹256.95 ₹341.55
Trend Signals
  • Price vs 50-DMAAbove
  • Price vs 200-DMAAbove
  • Golden Cross8d ago
  • RSI (14)65.67 · Neutral
Price Performance
1M+13.94%
3M+25.39%
6M+6.55%
1Y+27.49%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

NSE TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Profit CAGR of 33.9% over 5 years.
  • In a confirmed uptrend (50-DMA above 200-DMA).

CONS

No notable concerns flagged.

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-11.92
Industry PE
39.97
Forward P/E
-
PEG Ratio
-
Book Value
₹201.47
Price to Book
1.68
P/S
0.78
EV/EBITDA
194.07
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
8.00%
Profit 5Y
33.88%
Revenue (YoY)
20.02%
Earnings (YoY)
-

Profitability & Returns

ROCE
-0.19%
ROE
0.18%
ROA
0.13%
Profit Margin
0.09%
Op Margin
-5.38%
Gross Margin
7.59%
EPS (Latest Qtr)
₹-3.51
EPS (TTM)
₹-28.66

Balance Sheet & Liquidity

Debt/Equity
4.00
Quick Ratio
0.63
Current Ratio
2.22
Debt
₹25.66 Cr
Total Assets
₹935.77 Cr
Current Assets
₹202.55 Cr
Working Capital
₹111.31 Cr

Ownership

Promoter Holding
79.72%
Chg in Prom Hold
-1.10%
FII / Inst Holding
1.23%
Chg in FII Hold
-3.54%

Financial Snapshot

Enterprise Value
₹1,086.49 Cr
Total Revenue (TTM)
₹1,307.65 Cr
EBITDA
₹5.03 Cr
Free Cash Flow
₹-88.76 Cr
Operating Cash Flow
₹-73.83 Cr
Shares Outstanding
₹3.18 Cr
Gross Margin
7.59%
Payout Ratio
0.00%

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 HEALTHX Health X Platform Limited NSEPHARMA 341.55 -11.92 ₹1,086.49 Cr 0.00% -0.19% 0.18% 8.00% 33.88%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,948.80 40.77 ₹4.68 L Cr 0.83% 17.94% 13.74% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 7,315.50 75.61 ₹1.94 L Cr 0.44% 18.96% 15.32% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,952.20 87.70 ₹1.68 L Cr 0.78% 9.05% 25.79% 13.27% 20.22%
5 APOLLOHOSP Apollo Hospitals Enterprise Limited NIFTY50NSEAIPHARMA 8,981.00 66.51 ₹1.29 L Cr 0.23% 19.79% 20.48% 15.33% 33.34%
6 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,440.10 22.07 ₹1.16 L Cr 0.90% 14.86% 11.27% 7.23% 11.45%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,137.40 22.71 ₹1.14 L Cr 0.09% 19.04% 18.59% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,494.30 21.42 ₹1.14 L Cr 0.72% 28.42% 23.76% 19.10% 131.46%
9 MAXHEALTH Max Healthcare Institute Limited NSEAIPHARMA 1,099.00 99.82 ₹1.07 L Cr 0.18% 12.57% 13.42% 22.37% 9.34%
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in INR.

Metric Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue 313.00 Cr336.00 Cr358.00 Cr374.00 Cr307.00 Cr270.00 Cr274.00 Cr-282.13 Cr278.74 Cr309.01 Cr341.52 Cr378.36 Cr
Cost of Revenue --------265.30 Cr257.60 Cr285.00 Cr315.21 Cr350.60 Cr
Gross Profit --------16.83 Cr21.14 Cr24.01 Cr26.30 Cr27.77 Cr
Operating Expenses 324.00 Cr327.00 Cr355.00 Cr371.00 Cr317.00 Cr273.00 Cr278.00 Cr-47.07 Cr35.94 Cr40.27 Cr43.05 Cr50.32 Cr
Operating Income -14.00 Cr7.00 Cr1.00 Cr1.00 Cr-14.00 Cr-4.00 Cr-6.00 Cr--30.24 Cr-14.80 Cr-16.26 Cr-16.75 Cr-22.55 Cr
EBITDA -11.00 Cr9.00 Cr3.00 Cr3.00 Cr-11.00 Cr-2.00 Cr-5.00 Cr--3.28 Cr31.44 Cr-17.27 Cr3.26 Cr-12.40 Cr
Interest Expense 0000000-1.30 L8.60 L3.79 L16.96 L48.82 L
Pretax Income -6.00 Cr19.00 Cr11.00 Cr21.00 Cr5.00 Cr25.00 Cr-174.00 Cr--4.63 Cr30.19 Cr-18.64 Cr91.87 L-14.83 Cr
Tax Provision -17.28 Cr-5.51 Cr-2.53 Cr84.00 L-29.15 Cr-25.75 Cr22.62 Cr--22.21 Cr3.59 Cr-3.20 Cr55.00 L-1.86 Cr
Net Income -48.00 Cr-0-12.00 Cr-3.00 Cr22.00 Cr41.00 Cr-155.00 Cr-13.67 Cr23.91 Cr-12.69 Cr1.13 Cr-11.17 Cr
Diluted EPS -10.750.41-2.55-0.245.179.79-34.39-4.307.52-3.990.35-3.51

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue 52.00 Cr89.00 Cr135.00 Cr162.00 Cr222.00 Cr388.00 Cr551.00 Cr-1,038.19 Cr1,356.07 Cr1,089.53 Cr1,307.65 Cr
Cost of Revenue --------967.03 Cr1,236.12 Cr1,017.41 Cr1,208.40 Cr
Gross Profit --------71.15 Cr119.95 Cr72.12 Cr99.25 Cr
Operating Expenses 62.00 Cr116.00 Cr155.00 Cr175.00 Cr255.00 Cr440.00 Cr561.00 Cr-122.59 Cr142.92 Cr155.40 Cr169.58 Cr
Operating Income -16.00 Cr-35.00 Cr-27.00 Cr-19.00 Cr-39.00 Cr-57.00 Cr-14.00 Cr--51.44 Cr-22.96 Cr-83.28 Cr-70.33 Cr
EBITDA -10.00 Cr-28.00 Cr-20.00 Cr-13.00 Cr-33.00 Cr-52.00 Cr-10.00 Cr--113.19 Cr-20.35 Cr-186.81 Cr5.03 Cr
Interest Expense 1.00 Cr2.00 Cr3.00 Cr1.00 Cr3.00 Cr1.00 Cr3.00 Cr-86.76 L1.01 Cr21.72 L78.17 L
Pretax Income -15.00 Cr-37.00 Cr-28.00 Cr-12.00 Cr-42.00 Cr-58.00 Cr-16.00 Cr--122.25 Cr-30.50 Cr-192.86 Cr-2.36 Cr
Tax Provision 037.00 L-56.00 L-2.28 Cr-1.26 Cr5.22 Cr-64.00 L--22.78 Cr-36.35 Cr-70.12 Cr-91.03 L
Net Income -15.00 Cr-37.00 Cr-29.00 Cr-15.00 Cr-43.00 Cr-52.00 Cr-17.00 Cr--72.21 Cr8.88 Cr-91.17 Cr1.18 Cr
Diluted EPS -4.68-11.51-9.00-3.73-11.81-12.19-3.27197.04-22.702.79-28.66-

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets 281.00 Cr256.00 Cr251.00 Cr235.00 Cr230.00 Cr316.00 Cr293.00 Cr-1,205.82 Cr1,149.59 Cr974.37 Cr935.77 Cr
Current Assets --------486.21 Cr589.99 Cr579.61 Cr202.55 Cr
Cash & Equivalents --------31.72 Cr31.31 Cr12.42 Cr30.19 Cr
Inventory --------180.83 Cr115.79 Cr110.29 Cr144.65 Cr
Receivables --------35.08 Cr34.79 Cr9.98 Cr7.66 Cr
Total Liabilities --------212.26 Cr150.06 Cr109.84 Cr170.50 Cr
Current Liabilities --------89.18 Cr74.11 Cr98.02 Cr91.24 Cr
Long Term Debt -------0---22.09 Cr
Total Debt 5.00 Cr19.00 Cr21.00 Cr12.00 Cr2.00 Cr8.00 Cr12.00 Cr-9.33 Cr3.88 Cr91.90 L25.66 Cr
Total Equity 255.00 Cr218.00 Cr195.00 Cr176.00 Cr143.00 Cr210.00 Cr200.00 Cr-753.40 Cr762.37 Cr669.87 Cr640.89 Cr
Shares Outstanding --------3.18 Cr3.18 Cr3.18 Cr3.18 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -12.00 Cr-12.00 Cr-2.00 Cr-49.00 Cr-30.00 Cr-69.00 Cr-31.00 Cr--111.97 Cr35.86 Cr-17.31 Cr-73.83 Cr
Investing Cash Flow 7.00 Cr-1.00 Cr4.00 Cr15.00 Cr-2.00 Cr-22.00 Cr21.00 Cr-132.52 Cr-33.93 Cr-1.13 Cr171.19 Cr
Financing Cash Flow 4.00 Cr13.00 Cr5.00 Cr33.00 Cr26.00 Cr103.00 Cr4.00 Cr--1.83 Cr-2.35 Cr-44.31 L-79.59 Cr
Capital Expenditure -16.00 Cr-6.00 Cr2.00 Cr-6.00 Cr-3.00 Cr-2.00 Cr0--19.49 Cr-14.23 Cr-10.36 Cr-14.93 Cr
Free Cash Flow -28.00 Cr-18.00 Cr-0-55.00 Cr-33.00 Cr-71.00 Cr-31.00 Cr--131.46 Cr21.63 Cr-27.67 Cr-88.76 Cr
Net Change in Cash -1.00 Cr-07.00 Cr-2.00 Cr-6.00 Cr11.00 Cr-5.00 Cr-18.72 Cr-41.41 L-18.89 Cr17.77 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % --------6.9%8.8%6.6%7.6%
Operating Margin % -30.8%-39.3%-20.0%-11.7%-17.6%-14.7%-2.5%--5.0%-1.7%-7.6%-5.4%
Net Margin % -28.8%-41.6%-21.5%-9.3%-19.4%-13.4%-3.1%--7.0%0.7%-8.4%0.1%
ROE % -5.9%-17.0%-14.9%-8.5%-30.1%-24.8%-8.5%--9.6%1.2%-13.6%0.2%
ROCE % ---------4.6%-2.1%-9.5%-8.3%

Shareholding Pattern

Insiders
79.72%
Institutions
1.23%
Public Float
6.07%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for HEALTHX

Google News ue, 07 Apr 2026

Women’s HealthX brings together leading pharma innovators advancing the future of women’s healthcare - FemTech World

<a href="https://news.google.com/rss/articles/CBMi5gFBVV95cUxNN0VheEpOTHo4WTUyNldZTVFwZUY3RmJWZVlPbGVWTmdkamdKTW54Z0otdEVnQlJtb2hGQUplMlc3Sk53NktkT3BaLVpSX1BuN3ctZm5LVHI3RjhtWHFqX2FRdHVSUklWYkxNZTFXQUZmbEZpc3hDbXkza1dhdmRfbElEYnlpYU5Va2lYZE…

Google News Fri, 19 Jun 2026

Health X Platform narrows EBITDA loss, targets ₹6,000 cr revenue by FY30 - scanx.trade

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPczNlX2J3TDJIUHM5RWMxTElHQ1Vqb09BeEs2VDJBYWxsVHNSaWlGZ1RVMzFTNmJJUDAwRjlXN3BCOENaV05wNmtZbmZqREJMRi1fXzlDcGFKVDV6QXhUX3FHZW85Rm53OFd4ZTRSZ2gycHpmSlVfU2VhVF9GNUJkYjFNeGg4MWNYWDQ2R3…

Google News Wed, 29 Apr 2026

Health X Platform Ltd. Share Price Today - Health X Platform Ltd. Stock Price Live NSE/BSE - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMigwFBVV95cUxQRDEtc2hrUzIwSFBMNDBiVGNMd1U2OXEwRUhQUXFEMGVDbTJkV3RCSW1rUDY2SzVNeTltSlRrdDEyX0FZNVFwU2lMSm44R2xDXzhMRWJZaUx4cWV2NEYtbkYxZ2o4blRiZHJiMURxcDVoMXFiSS1vWi1ZS19hWDEzalZHTQ?oc=5" targe…

Google News Fri, 13 Feb 2026

Sastasundar Ventures Limited will Change its Name to Health X Platform Limited - marketscreener.com

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxNZE5XOXZDbldUWUU0LW4zUHpIQjQ0LUZSdTZCZ3RUcS1PWFFxbW9MVkROSUlTOHh1bFhuM1BKZS1CU1had0RlWVJMVVM1Y0M4VXRucWJTS0pzNG0zdFNUNW9GMmRQcWxKS3lMX3MwQzVoakloSUhCLWNFc1MyUl9MaDFtc0tMaVFQWWhtVU…

Google News Mon, 01 Jun 2026

Health X Platform narrows FY26 net loss to ₹1.4 crore; revenue rises 20% - scanx.trade

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxPWU84eHI4V1ZaeUd3X25oU3RIVV9VaTZ5OEpWRnNNS0dWdjVuQmc5aS1UMDNyX2tValZLRVNMWlVpN2NleVRxR3VNTnNuVlNGT1BScjBxMElTVnBvZzZXeGpWRGEwb3BxVVlnaDRPamdEd0YxREFMTUVEcGoxZTd5cEdXbUFySmVEak0xV2…

Google News Fri, 17 Oct 2025

The future unveiled: Inside HealthX Elevate's grand finale - CNBC TV18

<a href="https://news.google.com/rss/articles/CBMisAFBVV95cUxPRF9ldnlyRE5vN2N3aEg1WU4wVWo1Wm1SbzVrMXQ3TV9ka2Q0akhpaDFWLUlBcVJVTE45by1FNGxVSDk5N2V2ODQ2aV9YTzhHcEpHWWtRZ2R6QkVaSGJtdGd0dGMxaGRqZ0piNmNjY3JiUzJRWnN5SENZRXFmMUxZUXI5VnVMRk5qRTJ2YX…

HEALTHX — Frequently Asked Questions

What is the current share price of Health X Platform Limited (HEALTHX)?

As of 2026-07-15 09:52 IST, Health X Platform Limited (HEALTHX) trades at ₹341.55 on NSE. Its 52-week range is ₹256.95 to ₹341.55.

What is the market capitalisation of HEALTHX?

Health X Platform Limited (HEALTHX) has a market capitalisation of ₹1,086.49 Cr on NSE.

What is the P/E ratio of HEALTHX?

HEALTHX trades at a trailing price-to-earnings (P/E) ratio of -11.92. The industry average P/E is 39.97. Its price-to-book (P/B) ratio is 1.68.

What is the return on equity (ROE) of HEALTHX?

HEALTHX has a return on equity (ROE) of 0.18%. Its return on capital employed (ROCE) is -0.19%.

Is HEALTHX a good stock to buy?

This page provides a data-driven analysis of Health X Platform Limited (HEALTHX), including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space